Palatin Technologies, Inc. Common Stock Cash Flow Conversion Efficiency
Palatin Technologies, Inc. Common Stock cash flow conversion efficiency. Based on the latest financial reports, Palatin Technologies, Inc. Common Stock (PTN) has a cash flow conversion efficiency ratio of -0.417x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.42 Million) by net assets ($10.59 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Palatin Technologies, Inc. Common Stock (1996–2025)
Cash flow conversion efficiency of Palatin Technologies, Inc. Common Stock from 1996 to 2025. This chart illustrates how Palatin Technologies, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Palatin Technologies, Inc. Common Stock (PTN) stock price for real-time trading data and today's change.
Palatin Technologies, Inc. Common Stock Cash Flow Conversion Ratio Explained
Palatin Technologies, Inc. Common Stock cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Palatin Technologies, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Palatin Technologies, Inc. Common Stock ranked by their cash flow conversion efficiency. Also see Palatin Technologies, Inc. Common Stock (PTN) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
OPTHEA LTD
F:UKJ
|
N/A |
|
Harper Hygienics S.A.
WAR:HRP
|
0.011x |
|
Chromocell Therapeutics Corporation
NYSE MKT:CHRO
|
0.069x |
|
Clemondo Group AB (publ)
ST:CLEM
|
-0.005x |
|
CWG Holdings Bhd
KLSE:9423
|
0.035x |
|
ES Energy Save Holding AB
ST:ESGR-B
|
0.022x |
|
Real Heart
ST:HEART
|
-0.026x |
|
Organoclick AB
ST:ORGC
|
0.126x |
Annual Cash Flow Conversion Efficiency for Palatin Technologies, Inc. Common Stock (1996–2025)
The table below shows the annual cash flow conversion efficiency of Palatin Technologies, Inc. Common Stock from 1996 to 2025. Review cash generation quality of Palatin Technologies, Inc. Common Stock to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $-4.78 Million | $-21.31 Million | 4.460x | -98.42% |
| 2024-06-30 | $-111.50K | $-31.46 Million | 282.173x | +1865.82% |
| 2023-06-30 | $-1.98 Million | $-28.42 Million | 14.354x | +880.37% |
| 2022-06-30 | $16.27 Million | $-29.92 Million | -1.839x | -303.25% |
| 2021-06-30 | $49.65 Million | $-22.65 Million | -0.456x | -188.49% |
| 2020-06-30 | $80.17 Million | $41.33 Million | 0.515x | +337.94% |
| 2019-06-30 | $100.55 Million | $-21.78 Million | -0.217x | -443.00% |
| 2018-06-30 | $26.96 Million | $1.70 Million | 0.063x | +102.53% |
| 2017-06-30 | $-5.16 Million | $12.88 Million | -2.494x | -192.61% |
| 2016-06-30 | $-17.59 Million | $-47.36 Million | 2.693x | +346.07% |
| 2015-06-30 | $12.20 Million | $-13.36 Million | -1.095x | +12.23% |
| 2014-06-30 | $9.79 Million | $-12.21 Million | -1.247x | -109.95% |
| 2013-06-30 | $22.98 Million | $-13.65 Million | -0.594x | +92.98% |
| 2012-06-30 | $1.83 Million | $-15.49 Million | -8.459x | -1295.05% |
| 2011-06-30 | $18.19 Million | $-11.03 Million | -0.606x | +1.39% |
| 2010-06-30 | $9.32 Million | $-5.73 Million | -0.615x | +62.57% |
| 2009-06-30 | $3.31 Million | $-5.44 Million | -1.643x | +47.69% |
| 2008-06-30 | $6.55 Million | $-20.58 Million | -3.141x | -163.94% |
| 2007-06-30 | $18.53 Million | $-22.05 Million | -1.190x | +7.13% |
| 2006-06-30 | $18.30 Million | $-23.45 Million | -1.281x | -133.44% |
| 2005-06-30 | $9.23 Million | $-5.06 Million | -0.549x | +55.18% |
| 2004-06-30 | $19.39 Million | $-23.74 Million | -1.225x | -14.86% |
| 2003-06-30 | $18.66 Million | $-19.89 Million | -1.066x | +29.55% |
| 2002-06-30 | $8.69 Million | $-13.15 Million | -1.513x | -114.75% |
| 2001-06-30 | $11.92 Million | $-8.40 Million | -0.705x | +43.02% |
| 2000-06-30 | $6.91 Million | $-8.54 Million | -1.237x | +96.43% |
| 1999-06-30 | $300.00K | $-10.40 Million | -34.667x | -1492.79% |
| 1998-06-30 | $3.40 Million | $-7.40 Million | -2.176x | -420.23% |
| 1997-06-30 | $9.80 Million | $-4.10 Million | -0.418x | +56.18% |
| 1996-06-30 | $2.84 Million | $-2.71 Million | -0.955x | -- |
About Palatin Technologies, Inc. Common Stock
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, … Read more